How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema

Abstract Background Intravitreal anti-vascular endothelial growth factor (VEGF) treatment for diabetic macular oedema (DME) may begin with several initial monthly doses. Characteristics, treatment patterns and outcomes were compared for eyes with DME that did and did not receive such initial doses....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rishi P. Singh, David Tabano, Blanche L. Kuo, Andrew LaPrise, Theodore Leng, Eunice Kim, Meghan Hatfield, Vincent Garmo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-12-01
coleção:	BMC Ophthalmology
Assuntos:	Diabetic macular oedema Anti-vascular endothelial growth factor Intravitreal injections Loading dose
Acesso em linha:	https://doi.org/10.1186/s12886-024-03797-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!